JPWO2021202800A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021202800A5 JPWO2021202800A5 JP2022560154A JP2022560154A JPWO2021202800A5 JP WO2021202800 A5 JPWO2021202800 A5 JP WO2021202800A5 JP 2022560154 A JP2022560154 A JP 2022560154A JP 2022560154 A JP2022560154 A JP 2022560154A JP WO2021202800 A5 JPWO2021202800 A5 JP WO2021202800A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- mutant
- cas12i2
- composition
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 28
- 229920001184 polypeptide Polymers 0.000 claims 27
- 102000004196 processed proteins & peptides Human genes 0.000 claims 27
- 239000000203 mixture Substances 0.000 claims 14
- 210000004027 cell Anatomy 0.000 claims 8
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 125000006850 spacer group Chemical group 0.000 claims 4
- 108010066154 Nuclear Export Signals Proteins 0.000 claims 3
- 108010077850 Nuclear Localization Signals Proteins 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 238000012217 deletion Methods 0.000 claims 3
- 230000037430 deletion Effects 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 230000000536 complexating effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 108010077544 Chromatin Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 230000007067 DNA methylation Effects 0.000 claims 1
- 108010033040 Histones Proteins 0.000 claims 1
- 210000003483 chromatin Anatomy 0.000 claims 1
- 230000009918 complex formation Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 210000001808 exosome Anatomy 0.000 claims 1
- 102000034287 fluorescent proteins Human genes 0.000 claims 1
- 108091006047 fluorescent proteins Proteins 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 230000004807 localization Effects 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000002103 transcriptional effect Effects 0.000 claims 1
- 238000012800 visualization Methods 0.000 claims 1
Applications Claiming Priority (37)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003090P | 2020-03-31 | 2020-03-31 | |
| US202063002999P | 2020-03-31 | 2020-03-31 | |
| US202063003064P | 2020-03-31 | 2020-03-31 | |
| US63/003,090 | 2020-03-31 | ||
| US63/003,064 | 2020-03-31 | ||
| US63/002,999 | 2020-03-31 | ||
| US202063012007P | 2020-04-17 | 2020-04-17 | |
| US63/012,007 | 2020-04-17 | ||
| US202063026523P | 2020-05-18 | 2020-05-18 | |
| US202063026277P | 2020-05-18 | 2020-05-18 | |
| US202063026562P | 2020-05-18 | 2020-05-18 | |
| US202063026606P | 2020-05-18 | 2020-05-18 | |
| US63/026,277 | 2020-05-18 | ||
| US63/026,562 | 2020-05-18 | ||
| US63/026,523 | 2020-05-18 | ||
| US63/026,606 | 2020-05-18 | ||
| US202063063819P | 2020-08-10 | 2020-08-10 | |
| US202063063831P | 2020-08-10 | 2020-08-10 | |
| US202063063859P | 2020-08-10 | 2020-08-10 | |
| US202063063879P | 2020-08-10 | 2020-08-10 | |
| US63/063,831 | 2020-08-10 | ||
| US63/063,819 | 2020-08-10 | ||
| US63/063,879 | 2020-08-10 | ||
| US63/063,859 | 2020-08-10 | ||
| US202063085895P | 2020-09-30 | 2020-09-30 | |
| US202063085792P | 2020-09-30 | 2020-09-30 | |
| US202063085752P | 2020-09-30 | 2020-09-30 | |
| US202063085862P | 2020-09-30 | 2020-09-30 | |
| US63/085,862 | 2020-09-30 | ||
| US63/085,752 | 2020-09-30 | ||
| US63/085,792 | 2020-09-30 | ||
| US63/085,895 | 2020-09-30 | ||
| US202163147850P | 2021-02-10 | 2021-02-10 | |
| US202163147968P | 2021-02-10 | 2021-02-10 | |
| US63/147,850 | 2021-02-10 | ||
| US63/147,968 | 2021-02-10 | ||
| PCT/US2021/025257 WO2021202800A1 (en) | 2020-03-31 | 2021-03-31 | Compositions comprising a cas12i2 variant polypeptide and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520504A JP2023520504A (ja) | 2023-05-17 |
| JP2023520504A5 JP2023520504A5 (https=) | 2024-04-11 |
| JPWO2021202800A5 true JPWO2021202800A5 (https=) | 2024-04-11 |
Family
ID=75640000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560154A Pending JP2023520504A (ja) | 2020-03-31 | 2021-03-31 | Ｃａｓ１２ｉ２変異体ポリペプチドを含む組成物及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230332119A1 (https=) |
| EP (1) | EP4127154A1 (https=) |
| JP (1) | JP2023520504A (https=) |
| KR (1) | KR20230009379A (https=) |
| CN (2) | CN121380024A (https=) |
| AU (1) | AU2021249119A1 (https=) |
| BR (1) | BR112022019713A2 (https=) |
| CA (1) | CA3177749A1 (https=) |
| CO (1) | CO2022015170A2 (https=) |
| IL (1) | IL296791A (https=) |
| MX (1) | MX2022012189A (https=) |
| WO (1) | WO2021202800A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| WO2021243267A2 (en) * | 2020-05-29 | 2021-12-02 | Arbor Biotechnologies, Inc. | Compositions comprising a cas12i2 polypeptide and uses thereof |
| US20230407343A1 (en) * | 2020-10-30 | 2023-12-21 | Arbor Biotechnologies, Inc. | Compositions comprising an rna guide targeting pdcd1 and uses thereof |
| IL308806A (en) * | 2021-06-01 | 2024-01-01 | Arbor Biotechnologies Inc | Gene editing systems including nuclease crisper and their uses |
| CA3222159A1 (en) | 2021-06-04 | 2022-12-08 | Arbor Biotechnologies, Inc. | Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereof |
| US20240261435A1 (en) | 2021-06-04 | 2024-08-08 | Arbor Biotechnologies, Inc. | Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereof |
| WO2022256655A2 (en) | 2021-06-04 | 2022-12-08 | Arbor Biotechnologies, Inc. | Gene editing systems comprising an rna guide targeting lactate dehydrogenase a (ldha) and uses thereof |
| KR20240052763A (ko) | 2021-08-11 | 2024-04-23 | 아버 바이오테크놀로지스, 인크. | 스타스민 2 (stmn2)를 표적화하는 rna 가이드를 포함하는 유전자 편집 시스템 및 이의 용도 |
| WO2023018856A1 (en) | 2021-08-11 | 2023-02-16 | Arbor Biotechnologies, Inc. | Gene editing systems comprising an rna guide targeting polypyrimidine tract binding protein 1 (ptbp1) and uses thereof |
| WO2023034475A1 (en) | 2021-09-01 | 2023-03-09 | Arbor Biotechnologies, Inc. | Cells modified by a cas12i polypeptide |
| US20230287456A1 (en) * | 2021-09-10 | 2023-09-14 | Arbor Biotechnologies, Inc. | Compositions comprising a cas12i polypeptide and uses thereof |
| KR20240111314A (ko) * | 2021-11-02 | 2024-07-16 | 후이다진 테라퓨틱스 (싱가포르) 피티이. 엘티디. | 신규 crispr-cas12i 시스템 및 그의 용도 |
| TW202334421A (zh) * | 2021-11-05 | 2023-09-01 | 美商阿伯生物技術公司 | 包含靶向ciita之rna引導之組合物及其用途 |
| WO2023122433A1 (en) | 2021-12-22 | 2023-06-29 | Arbor Biotechnologies, Inc. | Gene editing systems targeting hydroxyacid oxidase 1 (hao1) and lactate dehydrogenase a (ldha) |
| US20250101394A1 (en) * | 2022-01-24 | 2025-03-27 | Huidagene Therapeutics (Singapore) Pte. Ltd. | Novel crispr-cas12i systems and uses thereof |
| EP4514954A4 (en) * | 2022-04-25 | 2026-03-25 | Huidagene Therapeutics Singapore Pte Ltd | NEW CRISPR-CAS12I SYSTEMS AND THEIR USES |
| EP4627083A1 (en) | 2022-11-30 | 2025-10-08 | Arbor Biotechnologies, Inc. | Reverse transcriptase-mediated genetic editing of transthyretin (ttr) and uses thereof |
| WO2024173645A1 (en) | 2023-02-15 | 2024-08-22 | Arbor Biotechnologies, Inc. | Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript |
| AU2024369584A1 (en) | 2023-10-30 | 2026-04-09 | Allogene Therapeutics, Inc. | Cells expressing anti-cd19 chimeric antigen receptors and methods of use thereof |
| CN117431235A (zh) * | 2023-11-06 | 2024-01-23 | 微光基因(苏州)有限公司 | CRISPR-Cas系统及其应用 |
| WO2025147604A1 (en) | 2024-01-05 | 2025-07-10 | Arbor Biotechnologies, Inc. | Methods for treating primary hyperoxaluria via genetic editing of hydroxyacid oxidase 1 |
| WO2025171210A1 (en) | 2024-02-09 | 2025-08-14 | Arbor Biotechnologies, Inc. | Compositions and methods for gene editing via homology-mediated end joining |
| WO2026015829A2 (en) | 2024-07-12 | 2026-01-15 | Arbor Biotechnologies, Inc. | Small reverse transcriptases and gene editing systems comprising such |
| WO2026015832A2 (en) | 2024-07-12 | 2026-01-15 | Arbor Biotechnologies, Inc. | Reverse transcriptases and gene editing systems comprising such |
| CN120424908B (zh) * | 2025-07-10 | 2025-09-12 | 南京农业大学 | 一种基于LAMP与CRISPR/Cas的检测方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2931897T3 (en) | 2012-12-12 | 2018-02-05 | Broad Inst Inc | CONSTRUCTION, MODIFICATION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTICAL APPLICATIONS |
| EP3011030B1 (en) * | 2013-06-17 | 2023-11-08 | The Broad Institute, Inc. | Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation |
| AU2014346559B2 (en) | 2013-11-07 | 2020-07-09 | Editas Medicine,Inc. | CRISPR-related methods and compositions with governing gRNAs |
| PL3765615T3 (pl) * | 2018-03-14 | 2023-11-13 | Arbor Biotechnologies, Inc. | Nowe enzymy i układy crispr ukierunkowane na dna |
| KR20210139265A (ko) * | 2019-02-13 | 2021-11-22 | 빔 테라퓨틱스, 인크. | 표적 서열에서 핵염기를 변형하기 위한 아데노신 데아미나제 염기 편집기 및 이의 사용 방법 |
| WO2024178144A1 (en) * | 2023-02-22 | 2024-08-29 | Prime Medicine, Inc. | Methods and compositions for editing nucleotide sequences |
-
2021
- 2021-03-31 KR KR1020227037945A patent/KR20230009379A/ko active Pending
- 2021-03-31 MX MX2022012189A patent/MX2022012189A/es unknown
- 2021-03-31 CN CN202511379190.7A patent/CN121380024A/zh active Pending
- 2021-03-31 CA CA3177749A patent/CA3177749A1/en active Pending
- 2021-03-31 AU AU2021249119A patent/AU2021249119A1/en active Pending
- 2021-03-31 IL IL296791A patent/IL296791A/en unknown
- 2021-03-31 US US17/916,270 patent/US20230332119A1/en active Pending
- 2021-03-31 CN CN202180038904.1A patent/CN115698278B/zh active Active
- 2021-03-31 EP EP21720912.1A patent/EP4127154A1/en active Pending
- 2021-03-31 BR BR112022019713A patent/BR112022019713A2/pt unknown
- 2021-03-31 JP JP2022560154A patent/JP2023520504A/ja active Pending
- 2021-03-31 WO PCT/US2021/025257 patent/WO2021202800A1/en not_active Ceased
-
2022
- 2022-10-25 CO CONC2022/0015170A patent/CO2022015170A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021202800A5 (https=) | ||
| JP7399710B2 (ja) | エピジェネティックに調節される部位特異的ヌクレアーゼ | |
| WO2022253185A1 (zh) | Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用 | |
| JP2023022254A (ja) | Ｃｒｉｓｐｒ／ｃｐｆ１システム及び方法 | |
| US10669557B2 (en) | Targeted deletion of cellular DNA sequences | |
| KR101889589B1 (ko) | 변형 캐스케이드 리보핵단백질 및 이의 용도 | |
| CN111315889A (zh) | 提高同源重组的方法和其组合物 | |
| CN111757889A (zh) | 新型CRISPR/Cas12f酶和系统 | |
| CN111793627A (zh) | 利用人工构建rna编辑酶进行rna定点编辑及相关应用 | |
| CN110462034A (zh) | 化脓链球菌cas9突变基因和由其编码的多肽 | |
| CN111902536A (zh) | 用于真核基因组修饰的改造的cas9系统 | |
| US10253321B2 (en) | Methods, compositions and kits for a one-step DNA cloning system | |
| JP2026511580A (ja) | Ｃａｓタンパク質及びその突然変異体、並びに対応する遺伝子編集システム及び使用 | |
| CN105658792B (zh) | 靶向组蛋白乙酰化 | |
| JP2026500040A (ja) | 複合体及びその使用 | |
| CN116949039A (zh) | 基于crispr的成像标记系统及其用途 | |
| CN112592923A (zh) | Ires序列、ires序列的应用和多顺反子表达载体 | |
| CN111378047B (zh) | 一种提高蛋白表达的融合标签蛋白及其应用 | |
| KR102151064B1 (ko) | 매칭된 5' 뉴클레오타이드를 포함하는 가이드 rna를 포함하는 유전자 교정용 조성물 및 이를 이용한 유전자 교정 방법 | |
| CN117683749B (zh) | Cas蛋白及其应用 | |
| WO2018164457A1 (ko) | C2cL 엔도뉴클레아제를 포함하는 유전체 교정용 조성물 및 이를 이용한 유전체 교정 방법 | |
| WO2025010350A2 (en) | Compositions and methods for precise genome editing using retrons | |
| CN102549006A (zh) | 植物人工染色体及其制造方法 | |
| CN118086340A (zh) | 微型碱基编辑器及其构建方法与应用 | |
| CN102296087B (zh) | 基于枯草芽孢杆菌生物素连接酶的外源基因诱导表达调控系统及其构建方法 |